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ABSTRACT
Objective: To investigate the magnitude and pattern of hepatitis viral markers in feco-orally transmitted acute viral 
hepatitis with their relation to age and sex.
Methods: This prospective study was carried out in two groups of subjects including the study group of 600 patients 
with clinically suspected infectious hepatitis and control group of 200 patients showing no clinical evidence of acute 
infectious hepatitis. Serum samples were tested for the presence of anti-hepatitis A virus (HAV) IgM and Anti-hepatitis 
E virus (HEV) IgM antibodies using commercial ELISA test kits.
Results: The seroprevalence rate of feco-orally transmitted acute viral hepatitis was 11.8% in the study group compared 
to 4.5% in the control group (p=0.007). The prevalence of anti-HAV IgM was 8.3% while that of anti-HEV IgM was 3.5% 
in the same group. Maximum seropositivity of anti-HAV IgM was seen in 0-10 years of age in the study group (16.8%) 
followed by 11-20 years (7.2%) and 21-30 years (4.6%). In the study group, the maximum seropositivity of anti-HEV 
IgM was seen in 21-30 years (10.7%) followed by 31-40 years (2.9%), 11-20 years (2.7%) and 0-10 years (0.9%). Male 
predominance was seen in both types of acute viral hepatitis.
Conclusion: While HEV infection was predominantly seen in young adults, HAV infection was predominantly a child-
hood infection and its prevalence decreased by age. Being enterically transmitted viral diseases it is recommended that 
immunization programs, public awareness measures for hygiene and safe drinking water should be consolidated. J 
Microbiol Infect Dis 2013;3(4): 181-185
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Hindistan kentsel kesimde bir üçüncü basamak hastanesinde fekal-oral yolla bulaşan viral 
hepatit
ÖZET
Amaç: Fekal-oral yolla bulaşan akut viral hepatit belirleyicilerinin sıklığı ve özellikleri ile yaş ve cinsiyet ilişkilerinin be-
lirlenmesi. 
Yöntemler: Bu ileriye dönük araştırma klinik olarak infeksiyöz hepatitten şüphelenilen ve 600 hastayı içeren çalışma 
gurubu ve akut infeksiyöz hepatit kliniğine sahip olmayan ve 200 hastayı içeren kontrol gurubunda yapıldı. Hasta ve 
kontrol gurubuna ait serum örnekleri anti-hepatitis A virus (HAV) IgM ve anti-hepatitis E virus (HEV) IgM antikorlarının 
varlığı açısından ticari ELISA test kitleri ile tarandı. 
Bulgular: Çalışma gurubunda akut viral hepatit seroprevalansı % 11,8, kontrol gurubunda ise % 4,5 olarak belirlendi 
(p=0,007). Aynı gurupta anti-HAV IgM prevalansı % 8,3 ve anti-HEV IgM prevalansı %3,5 idi. Çalışma gurubunda en 
fazla anti-HAV IgM seropozitifliği 0-10 yaş gurubunda (%16,8), daha sonra 11-20 yaş gurubunda (%7,2) ve 21-30 yaş 
gurubunda (% 4,6) idi. Yine çalışma gurubunda en fazla anti-HEV IgM pozitifliği 21-30 yaş gurubunda (% 10,7) idi ve bu 
gurubu 31-40 yaş gurubu (% 2,9), 11-20 yaş gurubu (% 2,7) ve 0-10 yaş gurubu (% 0,9) takip ediyordu. Her iki tip akut 
viral hepatit için erkekler ağırlıktaydı. 
Sonuç: HEV infeksiyonu ağırlıklı olarak genç erişkin yaş gurubunda görülmekte iken, HAV infeksiyonu ağırlıklı olarak 
çocuk yaş gurubunda görülmekte ve prevalansı da yaşla birlikte azalmakta idi. Bu viral enfeksiyonların barsak yoluyla 
bulaşma özelliğinden dolayı aşılama programları ve halkın hijyen ve sağlıklı su tüketimi konusunda bilgilendirilmesinin 
gerektiğini düşünüyoruz. 
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INTRODUCTION
Hepatitis A and hepatitis E are enterically transmit-
ted viral illnesses of significant public health impor-
tance. Hepatitis A virus and Hepatitis E virus are 
both devoid of a lipid envelope and are stable when 
they are secreted from infected liver cells into the 
bile.1,2 They gain entry to the intestinal tract through 
this  route  and  are  spread  by  a  fecal-oral  mode.3 
They continue to be significant public health prob-
lem in India despite improving sanitation, health 
awareness and socio-economic conditions. Hepati-
tis A causes subacute disease of global prevalence 
affecting children which occurs sporadically or as 
outbreaks while Hepatitis E is the commonest cause 
of feco-orally transmitted viral hepatitis in adults oc-
curring as epidemics and point source outbreaks.4,5 
India is hyper-endemic for Hepatitis A and E.6
The prevalence of feco-orally transmitted viral 
hepatitis still remains debatable in developing and 
developed countries with only few prevalence stud-
ies from urban northern India on exposure and infec-
tion. There is paucity of data regarding prevalence 
of different markers of hepatitis and also their age 
and sex related prevalence.7 As most of the cases 
of enterically transmitted viral hepatitis are prevent-
able, the burden of the disease could be reduced to 
a considerable extent, if seroprevalence of different 
viruses are better known in different age groups.8 
For this reason, in this report we investigated the 
seroprevalence of acute viral hepatitis A and acute 
viral hepatitis E in an urban area of Northern India.
METHODS
This prospective study was conducted in the De-
partment of Microbiology at Lady Hardinge Medical 
College, New Delhi, which is a tertiary care hospital 
in urban Northern India, over a period of one year 
from  January  2008  to  December  2008.  Subjects 
were divided into 2 groups. Group 1 was the study 
group of 600 patients with clinically suspected infec-
tious hepatitis attending the outpatient department 
of various specialties in Kalawati Saran and Smt. 
Sucheta Kriplani Hospital, New Delhi both attached 
to Lady Hardinge Medical College. Group 2 was the 
control group of 200 patients showing no clinical 
evidence of acute infectious hepatitis.
Inclusion criteria
• Recent onset of jaundice (<6 months) defined by 
serum bilirubin level >2.5 mg/dl and/or increase in 
serum transaminases >5 times the upper limit of 
normal.
• Fever in absence of chronic liver disease or past 
history of jaundice. 
Exclusion criteria:
• History of chronic liver disease or past history of 
jaundice with duration of illness more than 6 months.
• Acute fatty liver of hepatitis or alcoholic hepatitis or 
intrahepatic cholestasis.
All the serum samples obtained from the subjects 
(study and control group) were tested for the pres-
ence of anti-hepatitis A virus (HAV) IgM and anti-
hepatitis  E  virus  (HEV)  IgM  using  commercially 
available enzyme-linked immunosorbent assay kits 
(ELISA; Biokit®, Barcelona, Spain). Informed con-
sent  and  institutional  review  board  approval  was 
taken from ethics committee for the study bearing 
protocol number MIC 07/312.
We used SPSS Ver. 10.0 (SPSS Inc. Chica-
go, Illinois) for the statistical analysis. The means 
of continuous variables were compared using the 
Student’s t-test and categorical variables were com-
pared using the Chi square test and the Fisher’s ex-
act test, as appropriate. A p value of less than 0.05 
was considered to be significant.
RESULTS
The  study  group  was  divided  age  wise  i.e.  0-10 
years, 11-20 years, 21-30 years, 31-40 years and 
>40 years. The study group comprised of 362 males 
and 238 females. The overall male to female ratio 
was  1.5:1  and  thus  a  male  preponderance  was 
seen  in  study  group.  The  control  group  (n=200) 
comprised of 121 males and 79 females with over-
all male to female ratio of 1.5:1. The mean age in 
the study group was 20.2 ± (SD) 15.2 years while in 
the control group it was 19.65±14.8 years. The dif-
ference between the mean age of study and control 
group was not statistically significant (p=0.46).
Overall  71  (11.8%)  cases  were  positive  for 
enterically  transmitted  viral  hepatitis  in  the  study 
group while 9 (4.5%) were positive in control group 
(p=0.007).  HAV  infection  was  seen  in  50  (8.3%) 
cases in the study group while 4 (2%) cases were 
seen in the control group (p=0.002). HEV infection 
was seen in 21 (3.5%) cases in the study group 
while 5 (2.5%) cases were seen in the control group 
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On observing age wise seropositivity of HAV, it 
was found that maximum seropositivity of anti-HAV 
IgM was in 0-10 years of age group in the study 
group (16.8%) followed by 11-20 years (7.2%) and 
21-30 years (4.6%). When compared to controls the 
anti-HAV IgM seropositivity was significantly high-
er in the study group in 0-10 years of age group 
(p=0.002). There was decrease in seroprevalence 
of HAV with an increase in age (Table 2).
Table 2. Comparison of distribution of hepatitis A virus se-
ropositivity by age between the study and control groups *
Age groups Study Group
n/N (%) (N=600)
Control Group
n/N (%) (N=200)
p-value
0-10 years 36/214 (16.8) 2/71 (2.8) 0.002
11-20 years 8/110 (7.2) 2/36 (5.5) 0.434
21-30 years 6/130 (4.6) 0/43 0.418
31-40 years 0/67 (0) 0/43 -
> 40 years 0/71 (0) 0/43 -
Total 50/600 (8.3) 4/600 (2) 0.002
*Data presented as n/N (%), n/N: number of test positive/
number of tested.
On observing age wise seropositivity of HEV it 
was found that maximum seropositivity of anti-HEV 
IgM was in the 21-30 years (10.7%) age group in 
the  study  group  followed  by  31-40  years  (2.9%), 
11-20 years (2.7%) and 0-10 years (0.9%; Table 3). 
In the control group the maximum seropositivity of 
HEV was seen in the 31-40 years (4.5%) age group 
followed by 0-10 years (2.8%), 11-20 years (2.7%) 
and 21-30 years (2.3%). Anti-HEV IgM seropositiv-
ity was significantly higher in the study group in 21-
30 years of age group then that of controls (10.7% 
vs. 2.3%; p=0.002; Table 3).
Table 3. Comparison of distribution of hepatitis E virus se-
ropositivity by age between the study and control groups *
Age groups Study Group
n/N (%) (N=600)
Control Group
n/N (%) (N=200) p-value
0-10 years 2/214 (0.9) 2/71 (2.8) 0.080
11-20 years 3/110 (2.7) 1/36 (2.7) 0.770
21-30 years 14/130 (10.7) 1/43 (2.3) 0.042
31-40 years 2/67 (2.9) 1/22 (4.5) 0.094
> 40 years 0/79 (0) 0/28 (0) -
Total 21/600 (3.5) 5/200 (2.5) 0.735
*Data presented as n/N (%), n/N: number of test positive/
number of tested
Serological markers
Study Group, n=600 (%) Control Group n=200 (%) p-value
Male Female Total Male Female Total
Anti-HAV IgM  32 (8.8) 18 (7.5) 50 (8.3) 3 (2.4) 1 (1.2) 4 (2) 0.002
Anti-HEV IgM  13 (3.4) 8 (3.3) 21 (3.5) 5 (4.1) 0 5 (2.5) 0.735
Total 45 (7.5) 26 (4.3) 71 (11.8) 8 (4) 1 (0.5) 9 (4.5) 0.007
*Data presented as n (%).
Table 1. Comparison 
of the overall serop-
revalence  of  acute  vi-
ral hepatitis A and E 
between the study and 
control groups *
DISCUSSION
Enterically transmitted acute viral hepatitis is a glob-
al public health concern associated with substantial 
morbidity and mortality.9-10 In our study, HAV was the 
major cause of feco-orally transmitted viral hepati-
tis. Seroprevalence of anti-HAV IgM recorded by dif-
ferent authors in and around Delhi in recent years 
is between 2.3% to 11.4%.11-15 Kar et al. found the 
seropositivity of anti-HAV IgM in 113 patients with 
acute viral hepatitis as 3.5%.11 Das et al. reviewed 
75 patients with acute viral hepatitis and found the 
overall infective pathology attributed to HAV as 5%.12 
Our findings were comparable with the recent stud-
ies and we found that the seroprevalence of acute 
HAV infection as 8.3%. This high incidence could be 
attributed to a constant increase in the population 
of Delhi. The increase in this population load leads 
to more than one third of the people residing below 
the poverty line with poor sanitation and low socio-
economic status. Water shortage, poor standard of 
living, fecal contamination of food and water are re-
sponsible for increased susceptibility for infection.
The  seroprevalence  rate  of  IgM  anti  HAV  in 
apparently healthy population in our study was 2% 
(Table  1). There  is  paucity  of  data  regarding  the 
prevalence of IgM anti HAV in the general popu-
lation. However, several authors have studied the 
pattern of anti-HAV IgG in healthy population.16,17 
On studying the trends of HAV infection in different 
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the seropositivity of HAV decreased so that none of 
the cases were positive in >30 years of age groups. 
Thus our study implied that HAV infection was the 
commonest cause of enterically transmitted acute 
viral  hepatitis  in  childhood.  Similar  trends  in  age 
wise seropositivities of Hepatitis A virus were seen 
by Poddar et al.18 who reviewed 197 children in less 
than 14 years of age group with acute viral hepatitis 
and found the prevalence of IgM anti HAV as 64.5% 
. Their finding was supported by the fact that popu-
lation comprised only of children less than 14 years 
of age and HAV infection was predominantly seen 
in childhood. Kaur et al.14 have also analyzed age 
wise seropositivity of HAV infection and they found 
that percentage positivity of anti-HAV IgM declined 
between childhood  (3.1%) and adulthood  (1.7%). 
Such trends showing a high incidence of HAV infec-
tion in less than 10 years of age is attributed to the 
fact that viral hepatitis A is predominantly an infec-
tion of childhood. The high prevalence rate in chil-
dren is attributed to their susceptibilities to infection 
due to poor hygiene, overcrowding and poor sani-
tary conditions, when there is abundant shedding of 
HAV in the faeces. In the control group, maximum 
seropositivity was seen in 11-20 years of age group 
(5.5%) followed by 0-10 years group (2.8%). Some 
recent studies of Delhi have shown that epidemio-
logical transition of HAV in India and concluded that 
the peak age of seroprevalence is shifting from 1st 
decade of life to 2nd and 3rd decades.13,19 HAV in-
fection is a vaccine preventable disease but in In-
dia, vaccination against HAV is still not included in 
the universal immunization program and also there 
are no recommended HEV vaccination strategies till 
date. Thus, target oriented measures should be un-
dertaken and vaccination program should be con-
solidated for HAV.
The  seroprevalence  rate  of  anti-HEV  IgM  in 
our study was 3.5% while in the control group it 
was 2.5% (Table 1). No outbreak of acute hepatitis 
E was reported during the study period. Although 
some authors have shown that the high prevalence 
rates of anti-HEV IgM in and around Delhi during 
the recent years, our study showed comparatively 
low prevalence rates as compared to others.14 This 
could be probably due to the fact that there was no 
outbreak of hepatitis reported during the course of 
our study. Secondly, our hospital is mainly a pedi-
atric institution and more than 50% of the patients 
studied  belonged  to  the  pediatric  age  group. As 
HEV infection is most common in young adults and 
less number of adults was included in our study, this 
could be another reason for low prevalence rates of 
HEV in our study. Delhi is an endemic zone for HEV 
and outbreaks have occurred from time to time.20,21 
HEV is widespread due to problems associated with 
increased size of population, population migration, 
poor sanitation and poor standards of living leading 
to increased susceptibilities to infection. Epidemics 
and point source outbreaks are common in rainy 
season when flooding leads to sewage contamina-
tion of drinking water.22 Our study implied that HEV is 
predominantly an infection of adults. Many authors 
have shown similar results.23,24 Mishra et al. studied 
569 hospitalized patients suspected of acute viral 
hepatitis and recorded high seroprevalence rates 
in adults as compared to adolescents and children 
i.e. 5% in adults versus 12% in children.20,23 Among 
the  seropositive  individuals,  male  preponderance 
was also noted similar to our results. The reason 
for increased trends of HEV infection with increased 
age could be due to the fact that symptomatic HEV 
infection is most common in young adults aged 15-
40 years and is uncommon in children. Although 
HEV  infection  is  frequent  in  children,  it  is  mostly 
asymptomatic and anicteric, in children under nine 
years of age in endemic hepatitis. Similar trends 
were recorded by Tandon et al. who showed that 
HEV was more common in adults as compared to 
children.24  HEV  infection  is  usually  a  self-limiting 
disease with low rate of fulminant hepatic failure. 
However, when the infection occurred in pregnancy, 
the consequences are particularly disastrous. In our 
study, the only 15 pregnant women were recorded 
and none of them had seropositivity against HEV 
(data not shown).
In conclusion, both HAV and HEV infection are com-
mon  causes  of  enterically  transmitted  acute  viral 
hepatitis in the region and hence, it is recommend-
ed that measures for public awareness regarding 
the spread, better sanitation facilities, safe drinking 
water and proper collection, treatment and disposal 
of sewage should be undertaken to limit spread. We 
recommend that the vaccination programs should 
be intensified.
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